R Kurzrock Selected Research

R Kurzrock Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 06/2001
4	Thrombocytopenia (Thrombopenia) 01/2005 - 01/2000
3	Breast Neoplasms (Breast Cancer) 12/2015 - 12/2013
3	Fatigue 09/2012 - 09/2001
2	Basal Cell Neoplasms (Basal Cell Cancer) 10/2019 - 11/2018
2	Neoplasm Metastasis (Metastasis) 04/2017 - 09/2012
2	Lymphoma (Lymphomas) 09/2012 - 09/2001
2	Edema (Dropsy) 01/2005 - 11/2001
2	Bone Marrow Failure Disorders 01/2005 - 11/2001
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2005 - 11/2003
2	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2003 - 05/2001
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2001 - 04/2000
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2001 - 04/2000
2	Hairy Cell Leukemia 09/2001 - 04/2000
2	Leukemia 11/2000 - 09/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024
1	Carcinoma (Carcinomatosis) 01/2020
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2018
1	Central Nervous System Diseases (CNS Diseases) 04/2017
1	Colorectal Neoplasms (Colorectal Cancer) 10/2015
1	Carcinogenesis 01/2015
1	Thyroid Neoplasms (Thyroid Cancer) 09/2013
1	Melanoma (Melanoma, Malignant) 08/2013
1	Adrenocortical Carcinoma 03/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2013
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2013
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2005
1	Refractory Anemia with Excess of Blasts (RAEM) 11/2003
1	Erdheim-Chester Disease 12/2001
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2001
1	Myalgia 11/2001

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 11/2001 - 09/2001
2	RNA (Ribonucleic Acid)IBA 03/2024 - 06/2014
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 12/2013
2	HhAntag691IBA 01/2020 - 11/2018
2	Lapatinib (GW572016)FDA Link 09/2015 - 12/2013
2	LigandsIBA 01/2015 - 05/2001
2	Interleukin-11 (Interleukin 11)IBA 01/2005 - 11/2001
2	Interferon-alpha (Interferon Alfa)IBA 12/2001 - 05/2001
2	Interleukin-6 (Interleukin 6)IBA 11/2001 - 01/2001
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2001 - 09/2001
2	Interleukin-10 (Interleukin 10)IBA 11/2001 - 01/2001
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2001 - 05/2001
2	Pentostatin (Nipent)FDA LinkGeneric 09/2001 - 04/2000
2	Proteins (Proteins, Gene)FDA Link 11/2000 - 09/2000
1	Drug CombinationsIBA 01/2023
1	CyclinsIBA 12/2022
1	atezolizumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	VemurafenibIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 11/2018
1	Estrogens (Estrogen)FDA Link 12/2015
1	Hormones (Hormone)IBA 12/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2015
1	pazopanib FDA Link 09/2015
1	MTOR InhibitorsIBA 07/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2015
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2014
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 12/2014
1	PBI-05204IBA 12/2014
1	RNA Precursors (Precursor, mRNA)IBA 06/2014
1	Bevacizumab (Avastin)FDA Link 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013
1	AlbuminsIBA 10/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2013
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 09/2013
1	Carcinoembryonic AntigenIBA 09/2013
1	Tumor Biomarkers (Tumor Markers)IBA 09/2013
1	Phosphotransferases (Kinase)IBA 09/2013
1	temsirolimus FDA Link 03/2013
1	Growth Factor ReceptorsIBA 03/2013
1	cixutumumabIBA 03/2013
1	Insulin (Novolin)FDA Link 03/2013
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	dabrafenibIBA 02/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2012
1	Transaminases (Aminotransferases)IBA 09/2012
1	Alanine Transaminase (SGPT)IBA 09/2012
1	Dihydrotachysterol (AT 10)IBA 09/2012
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 09/2012
1	liposomal doxorubicin (Doxil)FDA Link 05/2012
1	Bortezomib (Velcade)FDA Link 05/2012
1	Gemcitabine FDA Link 05/2012
1	N- (3- aminopropyl)- N- (1- (5- benzyl- 3- methyl- 4- oxo- (1,2)thiazolo(5,4- d)pyrimidin- 6- yl)- 2- methylpropyl)- 4- methylbenzamideIBA 01/2012
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2003
1	Lymphotoxin-alpha (Lymphotoxin)IBA 11/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2003
1	InterferonsIBA 12/2001

Therapy/Procedure

20	Therapeutics 01/2023 - 06/2001
3	Drug Therapy (Chemotherapy) 03/2013 - 09/2000
2	Immunotherapy 03/2024 - 01/2019
1	Aftercare (After-Treatment) 11/2018
1	Retreatment 10/2015
1	Precision Medicine 08/2015
1	Intravenous Infusions 06/2014
1	Injections 01/2005
1	Stem Cell Transplantation 01/2005